Enhancement of DNA vaccine potency in rhesus macaques by electroporation (Q47356192)

14 January 2018

title

Enhancement of DNA vaccine potency in rhesus macaques by electroporation (English)

1 reference

14 January 2018

1 reference

1 reference

11

Mark G Lewis

1 reference

14 January 2018

Gillis Otten

1

1 reference

14 January 2018

Mary Schaefer

2

1 reference

14 January 2018

Barbara Doe

3

1 reference

14 January 2018

Hong Liu

4

1 reference

14 January 2018

Indresh Srivastava

5

1 reference

14 January 2018

Jan zur Megede

6

1 reference

14 January 2018

Derek O'Hagan

7

1 reference

14 January 2018

John Donnelly

8

1 reference

14 January 2018

Georg Widera

9

1 reference

14 January 2018

Dietmar Rabussay

10

1 reference

14 January 2018

Susan Barnett

12

1 reference

14 January 2018

Jeffrey B Ulmer

13

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 June 2004

1 reference

14 January 2018

published in

Vaccine

1 reference

14 January 2018

volume

22

1 reference

14 January 2018

issue

19

1 reference

14 January 2018

page(s)

2489-2493

1 reference

14 January 2018

describes a project that uses

1 reference

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

DNA vaccines: immunology, application, and optimization*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Enhancement of DNA vaccine potency using conventional aluminum adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

DNA vaccination with the human immunodeficiency virus type 1 SF162DeltaV2 envelope elicits immune responses that offer partial protection from simian/human immunodeficiency virus infection to CD8(+) T-cell-depleted rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Protection against influenza B virus infection by immunization with DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Electroporation improves the efficacy of DNA vaccines in large animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Induction of immune responses by DNA vaccines in large animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Therapeutic perspectives of in vivo cell electropermeabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

The regulation of DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.073

10.1016/J.VACCINE.2003.11.073

7 January 2021

Identifiers

DOI

1 reference

14 January 2018

PubMed ID

15193413

1 reference

14 January 2018